CrowdStrike Unveils Charlotte Agentic SOAR to Orchestrate the Agentic Security Workforce
The orchestration layer of the Agentic Security Platform unites intelligent agents to coordinate real-time agent-to-agent and analyst-to-agent collaboration AUSTIN,... Read more.
E3 Lithium to Host Webinar on November 5, 2025 @ 9:00AM MT
CALGARY, Alberta–(BUSINESS WIRE)–E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), (“E3 Lithium” or the “Company”) a... Read more.
NHOA Energy Commissions a 50 MWh Energy Storage System in Sicily
The Vicari BESS, supplied on a turnkey EPC basis, integrates advanced storage technologies with two of ERG’s onshore wind farms, strengthening Sicily’s... Read more.
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced... Read more.
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced... Read more.
Tokyo Metropolitan Government Selects Japan Airlines Consortium to Join First Phase of “eVTOL Implementation Program” Featuring Archer’s Midnight Aircraft
Japan Airlines-led consortium, which features Archer’s Midnight as the intended aircraft, is selected by the Tokyo Metropolitan Government to participate... Read more.
Phillips & Cohen Associates’ Parent Company, PCA Global Ventures, Announces Strategic Leadership Appointments
MANCHESTER, United Kingdom–(BUSINESS WIRE)–PCA Global Ventures, the parent company of Phillips & Cohen Associates, Ardent Credit Services, Invenio... Read more.
MaaT Pharma Presents Updated Preclinical Data at SITC Annual Meeting Demonstrating Immune Activation and Anti-Tumor Activity of MaaT034
LYON, France–(BUSINESS WIRE)–$MAAT #ASH–Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology... Read more.
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
This approval is based on results showing the safety and effectiveness of Restylane Lyft in enhancing the chin profile, with high patient satisfaction and long-lasting... Read more.
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate”... Read more.